Rapamycin

Rapamycin - Effects on Alzheimer's and Cognitive Health

RESTOR: PK/PD mTORi Inhibition in Older Adults

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations

Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions

Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis

Combination Gerotherapeutic Interventions for Healthspan Improvement

Daily Topical Rapamycin for Vitiligo

TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients

Effect of Rapamycin in Ovarian Aging

Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies

Effect of mTOR Inhibition & Other Metabolism Modulating Interventions on the Elderly [SubStudy Rapa & cMRI to Evaluate Cardiac Function]

A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation

UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies

Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis

Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation

Rapamycin Treatment for ALS

The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular Hemorrhage

The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals

Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome